Page last updated: 2024-09-04

levofloxacin and dexchlorpheniramine

levofloxacin has been researched along with dexchlorpheniramine in 1 studies

Compound Research Comparison

Studies
(levofloxacin)
Trials
(levofloxacin)
Recent Studies (post-2010)
(levofloxacin)
Studies
(dexchlorpheniramine)
Trials
(dexchlorpheniramine)
Recent Studies (post-2010) (dexchlorpheniramine)
4,3465812,2091282433

Protein Interaction Comparison

ProteinTaxonomylevofloxacin (IC50)dexchlorpheniramine (IC50)
5-hydroxytryptamine receptor 4Cavia porcellus (domestic guinea pig)2.322
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)4.966
Muscarinic acetylcholine receptor M2Homo sapiens (human)6.994
Muscarinic acetylcholine receptor M4Homo sapiens (human)1.976
Muscarinic acetylcholine receptor M5Homo sapiens (human)1.043
Muscarinic acetylcholine receptor M1Homo sapiens (human)1.383
Alpha-2B adrenergic receptorHomo sapiens (human)4.607
Muscarinic acetylcholine receptor M3Homo sapiens (human)2.579
Sodium-dependent noradrenaline transporter Homo sapiens (human)4.966
Histamine H2 receptorHomo sapiens (human)8.368
5-hydroxytryptamine receptor 2AHomo sapiens (human)3.692
5-hydroxytryptamine receptor 2CHomo sapiens (human)2.322
Sodium-dependent serotonin transporterHomo sapiens (human)0.025
Histamine H1 receptorHomo sapiens (human)0.0063
Sodium-dependent dopamine transporter Homo sapiens (human)0.931
Sigma non-opioid intracellular receptor 1Homo sapiens (human)1.658

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

1 review(s) available for levofloxacin and dexchlorpheniramine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016